{
    "organizations": [],
    "uuid": "ff4bfa5b3bca9f4a70b523c265bed5280d8e7e16",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-arix-bioscience-says-autolus-limit/brief-arix-bioscience-says-autolus-limited-submitted-draft-registration-statement-ip-in-us-idUSFWN1QO03Y",
    "ord_in_thread": 0,
    "title": "BRIEF-Arix Bioscience Says Autolus Limited Submitted Draft Registration Statement IP In US",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 6 (Reuters) - Arix Bioscience Plc:\n* ‍ITS GROUP BUSINESS AUTOLUS LIMITED HAS CONFIDENTIALLY SUBMITTED A DRAFT REGISTRATION STATEMENT ON FORM F-1 TO U.S. SEC\n* ‍AUTOLUS ANNOUNCES CONFIDENTIAL SUBMISSION OF DRAFT REGISTRATION STATEMENT FOR POTENTIAL INITIAL PUBLIC OFFERING IN UNITED STATES​ Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-03-06T15:48:00.000+02:00",
    "crawled": "2018-03-07T19:23:32.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "arix",
        "bioscience",
        "plc",
        "group",
        "business",
        "autolus",
        "limited",
        "confidentially",
        "submitted",
        "draft",
        "registration",
        "statement",
        "form",
        "sec",
        "announces",
        "confidential",
        "submission",
        "draft",
        "registration",
        "statement",
        "potential",
        "initial",
        "public",
        "offering",
        "united",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}